Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.

Yang S, Yang L, Li X, Li B, Li Y, Zhang X, Ma Y, Peng X, Jin H, Li H.

Am J Cancer Res. 2019 Jul 1;9(7):1329-1353. eCollection 2019. Review.

2.

The role of autophagy in hepatocellular carcinoma: friend or foe.

Liu L, Liao JZ, He XX, Li PY.

Oncotarget. 2017 Apr 18;8(34):57707-57722. doi: 10.18632/oncotarget.17202. eCollection 2017 Aug 22. Review.

3.

Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma.

Huang F, Wang BR, Wang YG.

World J Gastroenterol. 2018 Nov 7;24(41):4643-4651. doi: 10.3748/wjg.v24.i41.4643. Review.

4.

Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma.

Li N, Zhu Y.

Therap Adv Gastroenterol. 2019 Jan 22;12:1756284818821560. doi: 10.1177/1756284818821560. eCollection 2019. Review.

5.

Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma.

Liu XW, Cai TY, Zhu H, Cao J, Su Y, Hu YZ, He QJ, Yang B.

Autophagy. 2014 Jan;10(1):111-22. doi: 10.4161/auto.26838. Epub 2013 Nov 11.

6.

Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.

Qiu L, Tang Q, Li G, Chen K.

Life Sci. 2017 Dec 15;191:273-282. doi: 10.1016/j.lfs.2017.10.007. Epub 2017 Oct 4. Review.

PMID:
28987633
7.

The Role of Autophagy in Hepatocellular Carcinoma.

Lee YJ, Jang BK.

Int J Mol Sci. 2015 Nov 6;16(11):26629-43. doi: 10.3390/ijms161125984. Review.

8.

Autophagy: Dual Response in the Development of Hepatocellular Carcinoma.

Yazdani HO, Huang H, Tsung A.

Cells. 2019 Jan 28;8(2). pii: E91. doi: 10.3390/cells8020091. Review.

9.

ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.

Wu FQ, Fang T, Yu LX, Lv GS, Lv HW, Liang D, Li T, Wang CZ, Tan YX, Ding J, Chen Y, Tang L, Guo LN, Tang SH, Yang W, Wang HY.

J Hepatol. 2016 Aug;65(2):314-24. doi: 10.1016/j.jhep.2016.04.019. Epub 2016 May 3.

PMID:
27154061
10.

MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma.

Espelt MV, Bacigalupo ML, Carabias P, Troncoso MF.

World J Hepatol. 2019 Apr 27;11(4):344-358. doi: 10.4254/wjh.v11.i4.344. Review.

11.

Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.

Fan Q, Yang L, Zhang X, Ma Y, Li Y, Dong L, Zong Z, Hua X, Su D, Li H, Liu J.

J Exp Clin Cancer Res. 2018 Jan 19;37(1):9. doi: 10.1186/s13046-018-0673-y.

12.

Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.

Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, Shi GM, Ke AW, Wang XY, Song K, Dai Z, Shen YH, Fan J.

Clin Cancer Res. 2011 Oct 1;17(19):6229-38. doi: 10.1158/1078-0432.CCR-11-0816. Epub 2011 Aug 8.

13.

Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.

Wu DH, Wang TT, Ruan DY, Li X, Chen ZH, Wen JY, Lin Q, Ma XK, Wu XY, Jia CC.

Biomed Pharmacother. 2018 Jan;97:195-202. doi: 10.1016/j.biopha.2017.10.025. Epub 2017 Nov 6.

PMID:
29091866
14.

The emergence of noncoding RNAs as Heracles in autophagy.

Zhang J, Wang P, Wan L, Xu S, Pang D.

Autophagy. 2017 Jun 3;13(6):1004-1024. doi: 10.1080/15548627.2017.1312041. Epub 2017 Apr 25. Review.

15.

Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.

Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC, Hwang SM, Hu YC.

Biomaterials. 2015 Mar;44:71-81. doi: 10.1016/j.biomaterials.2014.12.023. Epub 2015 Jan 12.

PMID:
25617127
16.

Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.

Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X, Zhang J, Ji L, Ren T, An J, Liu B, Nie Y, Xing J.

Autophagy. 2016 Jun 2;12(6):999-1014. doi: 10.1080/15548627.2016.1166318. Epub 2016 Apr 28.

17.

Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma.

Sun T, Liu H, Ming L.

Cell Physiol Biochem. 2017;44(2):716-727. doi: 10.1159/000485285. Epub 2017 Nov 23. Review.

18.

MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.

Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.

J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.

PMID:
24211739
19.

Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.

Hou W, Bonkovsky HL.

World J Gastroenterol. 2013 Nov 28;19(44):7836-45. doi: 10.3748/wjg.v19.i44.7836. Review.

20.

Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms.

Qiu L, Wang T, Xu X, Wu Y, Tang Q, Chen K.

Int J Mol Sci. 2017 Nov 23;18(12). pii: E2505. doi: 10.3390/ijms18122505. Review.

Supplemental Content

Support Center